Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CMAKY | NI |
|---|---|---|
| Price | $4.33 | $39.55 |
| Change today | ▲ 0.00% | ▲ 0.30% |
| Market cap | $18.96B | $18.97B |
| Return, 3 months | +11.4% | -16.2% |
| Return, year to date | +1.9% | -3.4% |
| Return, 1 year | -13.7% | -8.1% |
| P/E (TTM) | 5.2 | 21.0 |
| P/B | 0.2 | 2.0 |
| P/E percentile vs own 5y | – | 47th |
| Dividend yield | 5.84% | 2.93% |
| Revenue growth (YoY, latest qtr) | – | +4.6% |
| Net profit growth (YoY) | – | -63.3% |
| Gross margin | – | 50.8% |
| Operating margin | – | 27.1% |
| Net margin | – | 13.2% |
| Return on equity | – | 9.8% |
| Analyst target vs. price | – | +25.6% |
| Analyst buy share | – | 90% |
| RSI (14) | 46 | 39 |
| 30-day volatility | 63.7% | 13.2% |
| Max drawdown, 1 year | -32.0% | -20.0% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
